HAP Trading’s TG Therapeutics TGTX Stock Holding History

HAP Trading’s Portfolio TGTX Stock Details TGTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-293,500	Closed	-$54K	–	1289
2018 Q3	$54K	Buy	293,500 +248,500	+552%	+$2.84M	﹤0.01%	615
2018 Q2	$21K	Buy	+45,000	New	+$619K	﹤0.01%	803

Other funds holding TGTX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

HAP Trading's TGTX Position: Q1 2022 in Review

HAP Trading sold out of TG Therapeutics (TGTX) in Q1 2022, closing a stake of 24,120 shares — an estimated $279K sold.

HAP Trading first reported a position in TGTX in Q1 2015 and held it in 8 quarters. The position peaked at $1.4M in Q3 2021. 181 funds tracked by Wall St. Rank hold TGTX as of Q1 2022.

HAP Trading reported no remaining TG Therapeutics position as of Q1 2022 after selling out during the quarter.
HAP Trading sold 24,120 TG Therapeutics shares in Q1 2022, an estimated $279K.
HAP Trading first reported a position in TG Therapeutics in Q1 2015 and held it in 8 quarters.
HAP Trading's TG Therapeutics position peaked at $1.4M in Q3 2021.
181 funds tracked by Wall St. Rank held TG Therapeutics as of Q1 2022.

Based on HAP Trading's 13F filing for Q1 2022, filed 12 May 2022.